# Novo Nordisk reported a first-quarter adjusted operating profit that surpassed analyst expectations.

*biotech · news · 2026-05-06 · Devdiscourse*

## Key points

- Novo Nordisk's first-quarter adjusted operating profit exceeded analyst forecasts.
- Novo Nordisk is increasingly focusing on its new weight-loss pill to drive growth.
- The firm faces intensifying competition from Eli Lilly in the obesity treatment market.
- The obesity sector is experiencing a notable price war as firms battle for market share.

**Companies:** Eli Lilly, Novo Nordisk
**Countries:** Denmark, United States

[Read the full story on Devdiscourse](https://www.devdiscourse.com/article/headlines/3898178-novo-nordisks-profit-surges-amid-weight-loss-drug-competition)

---

Canonical: https://newsio.io/n/89524832-ee8c-46a7-aa08-38e77350e545/novo-nordisk-reported-a-first-quarter-adjusted-operating-profit-that-surpassed-a
Summarized by Newsio from Devdiscourse. https://newsio.io/how-it-works